Kevin J Gancarczyk

Introduction to Department of Defense Center for Prostate Disease Research Multicenter National Prostate Cancer Database, and analysis of changes in the PSA-era

J. Bishoff, J. Moul, C. Kane, 2001 .

Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms.

J. Bishoff, J. Moul, C. Kane, 2003, Urology.

Increasing the number of core samples taken at prostate needle biopsy enhances the detection of clinically significant prostate cancer.

John A. Taylor, D. Mcleod, Kevin J Gancarczyk, 2002, Urology.